Dr. Matt Gibson is a registered patent attorney whose practice focuses on all aspects of intellectual property law, with an emphasis in medical, pharmaceutical and biotechnology-related patent matters. As a member of the firm’s Biotech Industry Group, Matt assists biotech industry clients in protecting and enforcing their rights in patented discoveries and technology, trademarked products and services, copyrighted works, confidential and proprietary trade secrets, negotiated license agreements, and other business agreements involving intellectual property and biotechnical assets.
Matt has a broad range of knowledge and experience in the field of biotechnology. From 2001-2007, he served as a graduate research assistant at the University of Oklahoma Health Sciences Center, where he was responsible for performing basic science research toward his doctoral dissertation in cell biology. Matt’s graduate research focused on signal transduction pathways involved in epigenetics as well as epigenetic regulation of gene expression including DNA methylation and chromatin modification. Prior to pursuing his graduate degree, he served as a research associate in the basic science labs of the Oklahoma Foundation for Digestive Research. During this time, Matt’s research focused on the role of stress and anxiety on the perception of visceral pain in the gastrointestinal system and, more specifically, the anxiety and pain perception effects resulting from exposure of the amygdala to increased glucocorticoids.
Matt has co-authored several scientific articles as well as presented at numerous local, national and international symposiums on topics in the areas of physiology, neurobiology, molecular biology and cell biology. He has also been a guest lecturer on patent-related topics at the University of Oklahoma College of Law and Oklahoma Christian University’s MBA program.
Matt's achievements have earned him inclusion in Oklahoma Super Lawyers' list of "Oklahoma Rising Stars," which recognizes the state’s top up-and-coming attorneys.
Matt is a 2009 graduate of the University of Oklahoma College of Law. He also holds a B.S. degree in biology/pre-med from Oklahoma Christian University and a Ph.D. in cell biology from the University of Oklahoma Health Sciences Center.
Matt is active in the community, serving on the board of trustees for the Oklahoma Chapter of the Leukemia and Lymphoma Society. He also volunteers regularly at the Cross and Crown Mission in downtown Oklahoma City and participates in mission trips to Honduras to support the Predisan Medical Mission. Matt is a member of Quail Springs Church of Christ in Oklahoma City.
Publications in Progress
- D. A. Myers, M. S. Gibson, Jay Schulkin and Beverly Greenwood-Meerveld, “Corticosterone implants to the amygdala and type 1 CRH receptor regulation: Effects on behavior and colonic sensitivity,” Behav. Brain Res. 161 (2005) 39-44.
- B. Greenwood-Van Meerveld, M. S. Gibson, A. C. Johnson, and D. Sutkowski-Markmann, “NK1 receptor-mediated mechanisms regulate colonic hypersensitivity in the guinea pig,” Pharm Biochem Behav. 74 (2003) 1005-1013.
- B. Greenwood-Van Meerveld, M. S. Gibson, W. D. Gunter, J. D. Shepard, R. Foreman, and D. A. Myers, “Stereotaxic delivery of corticosterone to the amygdale modulates colonic sensitivity in rats,” Brain Research. 893 (2001) 135-142.
- M. S. Gibson, K. Hyatt, and D. A. Myers, “Retinoic acid-induced chromatin remodeling of the corticotrophin-releasing hormone promoter.” (expected publication in 2012)
- M. S. Gibson, K. Hyatt, and D. A. Myers, “ The role of ERK mediated pathways on CRH gene expression induced by retinoic acid in human neuroblastoma cells.” (2012)
- M. S. Gibson, W. D. Gunter, J. D. Shepard, D. A. Myers, R. Foreman, B. Greenwood-Van Meerveld, “Influence of anxiety on visceral sensitivity in rats.” Oklahoma Center for Neurosciences Annual Meeting, 1999.
- M. S. Gibson, W. D. Gunter, J. D. Shepard, D. A. Myers, R. Foreman, B. Greenwood-Van Meerveld, “The role of the central amygdaloid nucleus in the development of visceral hypersensitivity in rats.” Digestive Disease Week, San Diego, CA, 2000.
- S. Cochrane, M. S. Gibson, D. A. Myers, and B. Greenwood-Van Meerveld, “The role of CRF receptors in neutral pathways modulating colonic sensitivity in rats.” Oklahoma Center for Neuroscience Annual Meeting, Oklahoma City, OK, 2000.
- M. S. Gibson and B. Greenwood-Van Meerveld, “An acute inflammatory insult induces long-term colonic hypersensitivity in rats.” American College of Gastroenterology Annual Symposium, New York City, NY, 2000.
- B. Greenwood-Van Meerveld, M. S. Gibson, R. D. Foreman and D. A. Myers, “Stereotaxic delivery of corticosterone to the central amygdaloid nucleus modulates colonic pain in rats.” American Pain Society Annual Symposium, Atlanta, GA, 2000.
- B. Greenwood-Van Meerveld, M. S. Gibson, R. D. Foreman and D. A. Myers, “Central regulation of colonic sensitivity: importance of the central amygdaloid nucleus.” International Motility Society Annual Symposium, Madison, WI, 2001.
- M. S. Gibson, A. C. Johnson, D. Sutkowski-Markmann, and B. Greenwood-Van Meerveld, “The importance of NK1 receptor mediated mechanisms in the development of visceral hyperactivity in a guinea pig.” AGA Distinguished Abstract: Plenary Session. Digestive Disease Week, Atlanta, GA, 2001.
- S. Cochrane, M. S. Gibson, D. A. Myers, and B. Greenwood-Van Meerveld, “The role of CRF receptors in neural pathways modulating colonic sensitivity in rats.” Digestive Disease Week, Atlanta, GA, 2001.